Aquestive Therapeutics, Inc. ($AQST)
Jung Cassie โ Chief Operating Officer
Shares
42,500
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 4, 2026
EPS:Est: -0.13
Revenue:Est: $13.28M
Transaction Details
| Insider | Jung Cassie |
|---|---|
| Title | Chief Operating Officer |
| Transaction Date | Mar 9, 2026 |
| Expiration Date | Mar 9, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Non-Qualified Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 11, 2026 |
| Shares Purchased | 42,500 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 42,500 |
| Derivative | Derivative |
| Accession Number | 0001214659-26-003141 |
| Document | View SEC Filing |